Related Experiment Videos
Antiprogestins as a model for progesterone withdrawal
Hilary O D Critchley1, Rodney W Kelly, Robert M Brenner
1Obstetrics and Gynaecology, Centre for Reproductive Biology, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh EH16 4SB, Scotland, UK. hilary.critchley@ed.ac.uk
Steroids
|December 12, 2003
Summary
Antiprogestin administration mimics progesterone withdrawal, inducing endometrial inflammation and changes similar to menstruation. This provides a model for studying early pregnancy failure and menstrual disorders.
Area of Science:
- Reproductive biology
- Endocrinology
- Gynecology
Background:
- The endometrium prepares for implantation or undergoes menstruation and repair.
- Progesterone withdrawal initiates endometrial breakdown.
- Pharmacological agents studying sex steroid effects are crucial for understanding endometrial responses.
Purpose of the Study:
- To investigate local decidual events during progesterone withdrawal using mifepristone.
- To explore the role of these events in early pregnancy failure.
- To model spontaneous and induced abortion mechanisms.
Main Methods:
- Administration of the antiprogestin mifepristone to mimic progesterone withdrawal.
- Analysis of local inflammatory mediators in the decidua.
- Observation of endometrial changes during induced bleeding.
Main Results:
- Mifepristone administration up-regulates inflammatory mediators like NF-kappaB, IL-8, MCP-1, and COX-2 in decidua.
- Mifepristone-induced bleeding shows endometrial changes mirroring spontaneous menstruation, including COX-2 up-regulation and PGDH down-regulation.
- Progesterone antagonism provides a model for studying early pregnancy failure.
Conclusions:
- Antagonism of progesterone action triggers inflammatory responses in the decidua.
- This model aids in understanding mechanisms of early pregnancy loss and menstrual disorders.
- Findings may inform strategies for treating abnormal uterine bleeding.